Table 1 Hierarchical theoretical model of potential proactive action of the omeprazole family compounds against influenza viruses
From: Do the omeprazole family compounds exert a protective effect against influenza-like illness?
First Level | ||
|---|---|---|
Demographic characteristics | Lifestyle habits | Underlying Pathologies |
Aged 65 + | Smoking | Cardiovascular diseases |
Drinking | Hypertension | |
Respiratory diseases | ||
Diabetes | ||
Cancer | ||
Kidney diseases | ||
Dyslipidaemia | ||
Gastric ulcer | ||
Gastric diseases | ||
Second Level | ||
Drugs taken | ||
Fibrates | ||
Statins | ||
Antibiotics | ||
Omeprazole Family Compounds (OFC) | ||
Third Level | ||
Vaccination status | ||
Influenza vaccination | ||
Outcome | ||
Influenza-Like Illness (ILI) | ||